balance equationinconsistent2023-12-31
Withheld: assets, equity, liabilities could not be reconciled with the rest of this filer’s statement.
Revenue
$7.19M
Fiscal year ended 2026-06-30Operating income
$1.93M
Fiscal year ended 2026-06-30Free cash flow
$2.29M
Fiscal year ended 2026-06-30IMMUCELL CORP /DE/ (ICCC) reported revenue of $7.19M and net income of $1.83M for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from IMMUCELL CORP /DE/’s SEC filings, each linked to the filing it came from. It is classified by the SEC under In Vitro & In Vivo Diagnostic Substances.
Income
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.19M | $10.36M | $7.63M | $5.51M | $6.44M | $8.07M | Unavailable | $6.01M | $5.47M | $7.26M |
| Cost of revenue | $4.75M | $5.70M | $4.72M | $3.14M | $3.63M | $4.71M | Unavailable | $4.43M | $4.24M | $4.96M |
| Gross profit | $2.44M | $4.66M | $2.91M | $2.36M | $2.82M | $3.35M | Unavailable | $1.58M | $1.23M | $2.30M |
| Operating income | $1.93M | $1.97M | -$57.96K | $20.08K | $569.56K | $1.12M | Unavailable | -$574.89K | -$1.39M | -$300.05K |
| Net income | $1.83M | $1.94M | -$2.85M | -$139.75K | $501.88K | $1.45M | Unavailable | -$701.69K | -$1.53M | -$437.87K |
| Research & development | $119.65K | $317.69K | $758.86K | $694.31K | $831.86K | $756.85K | Unavailable | $786.14K | $1.03M | $1.26M |
| Weighted-average diluted shares | shares 9.19M | shares 9.05M | Unavailable | shares 9.05M | shares 9.03M | shares 8.98M | Unavailable | shares 8.16M | shares 7.81M | shares 7.75M |
| Pretax income | $1.88M | $1.95M | -$2.85M | -$135.29K | $503.78K | $1.45M | Unavailable | -$700.35K | -$1.53M | -$436.53K |
| Income tax expense | $45.95K | $12.52K | $3.31K | $4.46K | $1.90K | $1.90K | Unavailable | $1.34K | $1.34K | $1.34K |
| Diluted EPS | $0.20 | $0.21 | Unavailable | $-0.02 | $0.06 | $0.16 | Unavailable | $-0.09 | $-0.20 | $-0.06 |
| Selling, general & administrative | $2.38M | $2.37M | $2.21M | $1.65M | $1.42M | $1.48M | Unavailable | $1.37M | $1.59M | $1.33M |
| General & administrative | $1.27M | $1.14M | $1.13M | $729.42K | $720.42K | $622.84K | Unavailable | $528.27K | $601.63K | $531.94K |
| Selling & marketing | $1.11M | $1.23M | $1.08M | $919.29K | $696.09K | $856.66K | Unavailable | $844.04K | $984.96K | $800.92K |
Balance
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $8.86M | $6.81M | $3.81M | $3.89M | Unavailable | Unavailable | $3.76M | Unavailable | $1.32M | $960.35K |
| Total assets | $46.63M | $44.11M | $42.53M | $45.73M | $42.53M | $45.62M | $45.10M | $44.45M | $41.86M | $43.05M |
| Current assets | $21.08M | $18.86M | $16.94M | $16.83M | $17.14M | $15.92M | $15.04M | $13.89M | $10.79M | $11.35M |
| Total liabilities | $15.26M | $14.97M | $15.48M | $15.93M | $16.85M | $16.63M | $17.58M | $18.04M | $18.40M | $18.41M |
| Current liabilities | $4.44M | $3.91M | $3.98M | $4.00M | $4.45M | $3.87M | $4.41M | $4.47M | $4.56M | $4.18M |
| Total equity incl. NCI | $31.37M | $29.14M | $27.06M | $29.80M | $29.87M | $28.99M | $27.52M | $26.41M | $23.46M | $24.64M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $9.08M | $8.67M | $9.27M | $9.80M | $8.29M | $7.36M | $7.11M | $7.46M | $7.30M | $7.15M |
| Accounts receivable | $2.90M | $2.69M | $3.42M | $2.55M | $2.38M | $3.35M | $3.77M | $2.31M | $1.95M | $2.62M |
| Goodwill | $95.56K | $95.56K | $95.56K | $95.56K | $95.56K | $95.56K | $95.56K | $95.56K | $95.56K | $95.56K |
| Long-term debt | $6.80M | $7.07M | $7.49M | $7.90M | $8.26M | $8.65M | $9.04M | $9.42M | $9.80M | $10.17M |
| Accounts payable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Cash flow
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $3.02M | $3.57M | $482.54K | -$1.18M | $1.60M | $1.57M | Unavailable | -$639.33K | $581.78K | $418.50K |
| Capital expenditures | $733.94K | $177.23K | $172.31K | $593.92K | $155.16K | $329.05K | Unavailable | $88.41K | $110.74K | $70.36K |
| Investing cash flow | -$733.94K | -$167.23K | -$167.31K | -$592.02K | -$125.93K | -$329.05K | Unavailable | -$88.41K | -$106.24K | -$70.36K |
| Financing cash flow | -$237.56K | -$400.00K | -$394.60K | -$337.69K | -$76.45K | -$403.65K | Unavailable | $3.21M | -$111.60K | -$366.54K |
| Net change in cash | $2.05M | $3.01M | -$79.37K | -$2.11M | $1.40M | $841.14K | Unavailable | Unavailable | Unavailable | Unavailable |
| Stock-based compensation | $239.87K | $137.95K | $103.78K | $73.16K | $66.71K | $52.22K | Unavailable | $77.56K | $98.02K | $81.11K |
| Common dividends paid | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Depreciation & amortization | $470.62K | $531.45K | $709.47K | $708.67K | $679.04K | $686.77K | Unavailable | $685.93K | Unavailable | Unavailable |
Derived
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $2.29M | $3.40M | $310.24K | -$1.78M | $1.45M | $1.24M | Unavailable | -$727.74K | $471.04K | $348.15K |
| Gross margin | 33.9% | 45.0% | 38.2% | 42.9% | 43.7% | 41.6% | Unavailable | 26.3% | 22.5% | 31.6% |
| Operating margin | 26.9% | 19.0% | -0.8% | 0.4% | 8.8% | 13.9% | Unavailable | -9.6% | -25.3% | -4.1% |
| FCF margin | 31.8% | 32.8% | 4.1% | -32.3% | 22.4% | 15.4% | Unavailable | -12.1% | 8.6% | 4.8% |
| SBC / revenue | 3.3% | 1.3% | 1.4% | 1.3% | 1.0% | 0.6% | Unavailable | 1.3% | 1.8% | 1.1% |
| Current ratio | 4.75x | 4.82x | 4.26x | 4.21x | 3.85x | 4.12x | 3.41x | 3.11x | 2.37x | 2.71x |
| Revenue YoY growth | 11.5% | 28.4% | Unavailable | -8.4% | 17.8% | 11.2% | Unavailable | 11.4% | 54.9% | 110.6% |
| Net margin | 25.5% | 18.7% | -37.4% | -2.5% | 7.8% | 17.9% | Unavailable | -11.7% | -28.0% | -6.0% |
| R&D / revenue | 1.7% | 3.1% | 10.0% | 12.6% | 12.9% | 9.4% | Unavailable | 13.1% | 18.8% | 17.4% |
| CapEx / revenue | 10.2% | 1.7% | 2.3% | 10.8% | 2.4% | 4.1% | Unavailable | 1.5% | 2.0% | 1.0% |
| Long-term debt / equity | 0.22x | Unavailable | 0.28x | 0.27x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 2.4% | 0.6% | Unavailable | Unavailable | 0.4% | 0.1% | Unavailable | Unavailable | Unavailable | Unavailable |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open ICCC in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-13View SEC filing
10-Q · Filed 2026-05-14View SEC filing
10-K · Filed 2026-03-30View SEC filing
10-Q · Filed 2025-11-13View SEC filing
10-Q · Filed 2025-08-14View SEC filing
10-Q · Filed 2025-05-14View SEC filing
Reconciliation checks needing review
5 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
gross profit bridgeinconsistent2023-12-31
Withheld: cost revenue, revenue could not be reconciled with the rest of this filer’s statement.
balance equationinconsistent2022-12-31
Withheld: assets, equity, liabilities could not be reconciled with the rest of this filer’s statement.
gross profit bridgeinconsistent2022-12-31
Withheld: cost revenue, revenue could not be reconciled with the rest of this filer’s statement.
balance equationreview2025-06-30
Difference 4188451 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.